20 May 2003
Autoimmune reactions associated with HCV and HBV infections.
Z. Michalska, P. Stalke, K. Witczak-Malinowska, E. Lakomy, K. Sikorska, J. Stolarczyk, H. TrochaMed Sci Monit 2003; 9(2): 12-0 :: ID: 15262
Abstract
Background:HCV and HBV infection may release autoimmune reactions(AIR).Aim of the study was an assessment of the clinical courseof AIR among HCV and HBV infected patients and the revision of the applied treatment. Material/Methods:22 patients,16 HCV and 6 HBV infected were admitted to the hospital because of symptoms of viral hepatitis and autoimmune hepatitis AIH.Diagnosis of AIH was based on biochemical examinations,presence of autoantibodies and morphological changes in liver biopsy. HCV infection was confirmed by the presence of HCVRNA and HBV infection on the basis of serological markers. Results:The time to develop AIR in HCV infection remained unknown.In HBV infection it took 5 –18 years from the first detection of HBsAg to AIR diagnosis.HBeAg was negative in 5/6 cases of HBV infection.In all HCV cases,HCVRNA was positive.In the group of 22 HCV and HBV patients the titres of autoantibodies were high. The 6/16 HCV and 3/6 HBV patients suffered from extrahepatic localisation of the autoim- mune disease. Chronic hepatitis was confirmed by histological examinations of liver specimens in all patients. The morphological signs of AIH were demonstrated in 6 /16 HCV and 5/6 HBV cases.10/16 HCV and 3/6 HBV were treated with glycocorticoids,3/16 HCV and 2/6 HBV with glycocorticoids and azathioprine. Only 4/16 HCV patients received interferon alpha and 1 out of 6 HBV patients treated with lamivudine.The therapy was ineffective in most of the studied cases. Conclusions: AIR caused many difficulties in the diagnosis and therapy of liver diseases.
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Preoperative Blood Transfusion Requirements for Hemorrhoidal Severe Anemia: A Retrospective Study of 128 Pa...Med Sci Monit In Press; DOI: 10.12659/MSM.943126
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952